Under Political Pressure, FDA expands use of COVID-19 treatments without research to back it up
The U.S. Food and Drug Administration late Friday allowed the drug remdesivir to be used on all patients hospitalized with COVID-19, although no published research supports such widespread use. The move, which comes less than a week after the agency approved use of convalescent plasma – also with no published scientific support – has fueled concerns the agency is yielding to political pressure. "It seems to be a pattern of approval without […]
